Skip to content

A Randomized Controlled Trial on Assessment of the Efficacy of a Herbal Anaesthetic Gel for Painless Needle Prick in Neonates

Assessment of the Anaesthetic Potential of Akarkarabha & Lavanga Gel During Venipuncture in Neonates: A Randomized Controlled Clinical Trial - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063807
Enrollment
72
Registered
2024-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

DR CHHAVI ROSHA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Neonates who have completed 48 hours of life uneventfully post birth at the time of enrolment. 2. Neonates with a minimum weight of 2500 grams at the time of procedure. 3. Neonates born at or after 37 completed weeks of gestation. 4. Neonates free from major congenital abnormalities and are not on any life-support. 5. Neonates scheduled to undergo venipuncture for medical evaluation.

Exclusion criteria

Exclusion criteria: 1. Neonates with skin lesions, or dermatological disorders. 2. Neonates receiving any concurrent systemic medications, other than the nutritional supplements. 3. Neonates born to mothers with compromised immune systems or mothers found positive for any communicable or infectious disease. 4. Neonates currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study will be the assessment of Pain Perception experienced by the neonates during the venipuncture procedure. The pain scores obtained from the scales will be the primary outcome to determine the anaesthetic potential of Akarkarabha and Lavanga topical gel in reducing pain perception during venipuncture in neonates.Timepoint: All assessments will be conducted at the following time points: 1. Baseline, 2. during venipuncture, and 3. post-procedure (30 minutes after the venipuncture procedure).

Secondary

MeasureTime frame
As a secondary outcome, this study seeks to evaluate the incidence of sequelae or adverse events such as inflammation, erythema, oedema, alterations in skin integrity, localized infections, ecchymosis, delayed wound healing, & scar formation attributable to venipuncture within a 24-hour window following the application of Akarkarabha & Lavanga Gel at the venipuncture site.Timepoint: Within a 24-hour window following the application of Akarkarabha & Lavanga Gel at the venipuncture site.

Countries

India

Contacts

Public ContactDR RAHUL H GUJARATHI

Bharati Vidyapeeth (Deemed to be University) College of Ayurved, Pune

shrigujarathi@gmail.com919420322740

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026